To minimize bloating, start by observing how different foods affect your body
soluble fiber ferments in the gut into short-chain fatty acids (SCFAs) that stimulate L-cells to release GLP-1
By reducing fat mass and improving adipose tissue signaling, retatrutide may: Lower inflammatory cytokines Improve adipose tissue health Reduce metabolic stress on the liver, pancreas, and cardiovascular system These effects support broader metabolic improvement beyond cosmetic weight loss
65:e12525
The flexibility of weekly injections means your provider can pause dose increases if side effects emerge or advance them quickly if you tolerate the medication well
Use With Caution In Research Models Involving: Diabetes or impaired glucose regulation Insulin resistance or metabolic syndrome Cardiovascular disease or uncontrolled hypertension Fluid-retention susceptibility or fluid-balancerelated conditions Hormonal or endocrine disorders Sleep apnea or significant respiratory disorders Chronic migraines or neurological sensitivity Kidney or liver impairment Avoid or Carefully Evaluate in Research Models With: Active or suspected malignancies History of growth-sensitive tumors Severe uncontrolled endocrine disorders Severe uncontrolled cardiovascular disease Pregnancy or breastfeeding contexts Known hypersensitivity to peptide compounds Additional Research Considerations Because Ipamorelin may increase endogenous growth hormone and downstream IGF-1 activity, research involving abnormal cellular proliferation, tumor-growth pathways, or uncontrolled metabolic disease should be approached with particular caution
